There is one clinical trial.
SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.
Description: HYPONATREMIA AND MORTALITY
Measure: MORTALITY Time: 30 DAYSDescription: HYPONATREMIA AND ICU HOSPITALIZATION
Measure: ICU HOSPITALIZATION Time: 30 DAYS